Log In
Print this Print this

GM-CSF-adjuvanted DNA/MVA vaccine (GOVX-B21)

  Manage Alerts
Collapse Summary General Information
Company GeoVax Labs Inc.
DescriptionGranulocyte macrophage colony-stimulating factor (GM-CSF)-adjuvanted 2 component vaccine consisting of a recombinant DNA and a recombinant modified vaccinia Ankara (MVA), both of which express the gag, pol and env proteins of HIV-1
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationHIV / AIDS
Indication DetailsVaccinate against HIV/AIDS infection
Regulatory Designation


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today